{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:41:29Z","timestamp":1795030889908,"version":"4.10.2"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P50CA127297"],"award-info":[{"award-number":["P50CA127297"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA163649"],"award-info":[{"award-number":["R01CA163649"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA216853"],"award-info":[{"award-number":["R01CA216853"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA210240"],"award-info":[{"award-number":["U01CA210240"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R50CA211462"],"award-info":[{"award-number":["R50CA211462"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA036727"],"award-info":[{"award-number":["P30CA036727"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA210439"],"award-info":[{"award-number":["R01CA210439"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R50CA211462"],"award-info":[{"award-number":["R50CA211462"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P50CA127297"],"award-info":[{"award-number":["P50CA127297"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA210240"],"award-info":[{"award-number":["U01CA210240"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P50CA127297"],"award-info":[{"award-number":["P50CA127297"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2022,2,11]]},"DOI":"10.1038\/s41388-021-02132-6","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:02:56Z","timestamp":1641772976000},"page":"971-982","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["CD73 induces GM-CSF\/MDSC-mediated suppression of T cells to accelerate pancreatic cancer pathogenesis"],"prefix":"10.1038","volume":"41","author":[{"given":"Ryan J.","family":"King","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4490-8013","authenticated-orcid":false,"given":"Surendra K.","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunbo","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enza","family":"Vernucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuldeep S.","family":"Attri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneesha","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina V.","family":"Chaika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Abrego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venugopal","family":"Gunda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila G.","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Grandgenett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey J.","family":"Lazenby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Hollingsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8598-6352","authenticated-orcid":false,"given":"Kamiya","family":"Mehla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8903-0131","authenticated-orcid":false,"given":"Pankaj K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,10]]},"reference":[{"key":"2132_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"2132_CR2","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913\u201321.","journal-title":"Cancer Res"},{"key":"2132_CR3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"2132_CR4","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029\u201333.","journal-title":"Science"},{"key":"2132_CR5","doi-asserted-by":"publisher","first-page":"400","DOI":"10.4049\/jimmunol.1701041","volume":"200","author":"A Sugiura","year":"2018","unstructured":"Sugiura A, Rathmell JC. Metabolic barriers to T cell function in tumors. J Immunol. 2018;200:400\u20137.","journal-title":"J Immunol"},{"key":"2132_CR6","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1158\/1078-0432.CCR-17-0894","volume":"24","author":"DB Rivadeneira","year":"2018","unstructured":"Rivadeneira DB, Delgoffe GM. Antitumor T-cell reconditioning: improving metabolic fitness for optimal cancer immunotherapy. Clin Cancer Res. 2018;24:2473\u201381.","journal-title":"Clin Cancer Res"},{"key":"2132_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fonc.2017.00068","volume":"7","author":"S Gupta","year":"2017","unstructured":"Gupta S, Roy A, Dwarakanath BS. Metabolic cooperation and competition in the tumor microenvironment: implications for therapy. Front Oncol. 2017;7:68.","journal-title":"Front Oncol"},{"key":"2132_CR8","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1002\/1873-3468.12784","volume":"591","author":"V Molinier-Frenkel","year":"2017","unstructured":"Molinier-Frenkel V, Castellano F. Immunosuppressive enzymes in the tumor microenvironment. FEBS Lett. 2017;591:3135\u201357.","journal-title":"FEBS Lett"},{"key":"2132_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/imr.12528","volume":"276","author":"B Allard","year":"2017","unstructured":"Allard B, Longhi MS, Robson SC, Stagg J. The ectonucleotidases CD39 and CD73: novel checkpoint inhibitor targets. Immunol Rev. 2017;276:121\u201344.","journal-title":"Immunol Rev"},{"key":"2132_CR10","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3389\/fimmu.2019.00925","volume":"10","author":"S Vigano","year":"2019","unstructured":"Vigano S, Alatzoglou D, Irving M, Menetrier-Caux C, Caux C, Romero P, et al. Targeting adenosine in cancer immunotherapy to enhance T-cell function. Front Immunol. 2019;10:925.","journal-title":"Front Immunol"},{"key":"2132_CR11","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nrc.2017.86","volume":"17","author":"D Vijayan","year":"2017","unstructured":"Vijayan D, Young A, Teng MWL, Smyth MJ. Targeting immunosuppressive adenosine in cancer. Nat Rev Cancer. 2017;17:709\u201324.","journal-title":"Nat Rev Cancer"},{"key":"2132_CR12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nri2938","volume":"11","author":"WG Junger","year":"2011","unstructured":"Junger WG. Immune cell regulation by autocrine purinergic signalling. Nat Rev Immunol. 2011;11:201\u201312.","journal-title":"Nat Rev Immunol"},{"key":"2132_CR13","doi-asserted-by":"crossref","unstructured":"Dosch M, Gerber J, Jebbawi F, Beldi G. Mechanisms of ATP release by inflammatory cells. Int J Mol Sci. 2018;19:1222.","DOI":"10.3390\/ijms19041222"},{"key":"2132_CR14","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.3389\/fimmu.2017.01578","volume":"8","author":"H Zhao","year":"2017","unstructured":"Zhao H, Liao X, Kang Y. Tregs: where we are and what comes next? Front Immunol. 2017;8:1578.","journal-title":"Front Immunol"},{"key":"2132_CR15","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1161\/ATVBAHA.111.226837","volume":"32","author":"J Linden","year":"2012","unstructured":"Linden J, Cekic C. Regulation of lymphocyte function by adenosine. Arterioscler Thromb Vasc Biol. 2012;32:2097\u2013103.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2132_CR16","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1080\/08916930701464939","volume":"40","author":"PE Zarek","year":"2007","unstructured":"Zarek PE, Powell JD. Adenosine and anergy. Autoimmunity. 2007;40:425\u201332.","journal-title":"Autoimmunity"},{"key":"2132_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1182\/blood-2007-03-081646","volume":"111","author":"PE Zarek","year":"2008","unstructured":"Zarek PE, Huang CT, Lutz ER, Kowalski J, Horton MR, Linden J, et al. A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood. 2008;111:251\u20139.","journal-title":"Blood"},{"key":"2132_CR18","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1001\/jamaoncol.2019.1588","volume":"5","author":"EM O\u2019Reilly","year":"2019","unstructured":"O\u2019Reilly EM, Oh DY, Dhani N, Renouf DJ, Lee MA, Sun W, et al. Durvalumab with or without tremelimumab for patients with metastatic pancreatic ductal adenocarcinoma: a phase 2 randomized clinical trial. JAMA Oncol. 2019;5:1431\u20138.","journal-title":"JAMA Oncol"},{"key":"2132_CR19","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","volume":"366","author":"JR Brahmer","year":"2012","unstructured":"Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P, et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N. Engl J Med. 2012;366:2455\u201365.","journal-title":"N. Engl J Med"},{"key":"2132_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s40169-019-0226-9","volume":"8","author":"SK Daniel","year":"2019","unstructured":"Daniel SK, Sullivan KM, Labadie KP, Pillarisetty VG. Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma. Clin Transl Med. 2019;8:10.","journal-title":"Clin Transl Med"},{"key":"2132_CR21","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1172\/JCI0215337","volume":"110","author":"K Synnestvedt","year":"2002","unstructured":"Synnestvedt K, Furuta GT, Comerford KM, Louis N, Karhausen J, Eltzschig HK, et al. Ecto-5\u2019-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia. J Clin Invest. 2002;110:993\u20131002.","journal-title":"J Clin Invest"},{"key":"2132_CR22","doi-asserted-by":"publisher","first-page":"C799","DOI":"10.1152\/ajpcell.1989.256.4.C799","volume":"256","author":"GH Moser","year":"1989","unstructured":"Moser GH, Schrader J, Deussen A. Turnover of adenosine in plasma of human and dog blood. Am J Physiol. 1989;256:C799\u2013806.","journal-title":"Am J Physiol"},{"key":"2132_CR23","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.ccr.2012.04.025","volume":"21","author":"LJ Bayne","year":"2012","unstructured":"Bayne LJ, Beatty GL, Jhala N, Clark CE, Rhim AD, Stanger BZ, et al. Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell. 2012;21:822\u201335.","journal-title":"Cancer Cell"},{"key":"2132_CR24","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1007\/s00018-019-03048-x","volume":"76","author":"A Salminen","year":"2019","unstructured":"Salminen A, Kaarniranta K, Kauppinen A. Immunosenescence: the potential role of myeloid-derived suppressor cells (MDSC) in age-related immune deficiency. Cell Mol Life Sci. 2019;76:1901\u201318.","journal-title":"Cell Mol Life Sci"},{"key":"2132_CR25","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.ccr.2012.04.024","volume":"21","author":"Y Pylayeva-Gupta","year":"2012","unstructured":"Pylayeva-Gupta Y, Lee KE, Hajdu CH, Miller G, Bar-Sagi D. Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell. 2012;21:836\u201347.","journal-title":"Cancer Cell"},{"key":"2132_CR26","doi-asserted-by":"publisher","first-page":"422","DOI":"10.4049\/jimmunol.1701019","volume":"200","author":"S Ostrand-Rosenberg","year":"2018","unstructured":"Ostrand-Rosenberg S, Fenselau C. Myeloid-derived suppressor cells: immune-suppressive cells that impair antitumor immunity and are sculpted by their environment. J Immunol. 2018;200:422\u201331.","journal-title":"J Immunol"},{"key":"2132_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ccell.2017.06.004","volume":"32","author":"SK Shukla","year":"2017","unstructured":"Shukla SK, Purohit V, Mehla K, Gunda V, Chaika NV, Vernucci E, et al. MUC1 and HIF-1alpha signaling crosstalk induces anabolic glucose metabolism to impart gemcitabine resistance to pancreatic cancer. Cancer Cell. 2017;32:71\u201387 e77.","journal-title":"Cancer Cell"},{"key":"2132_CR28","doi-asserted-by":"publisher","first-page":"e1438107","DOI":"10.1080\/2162402X.2018.1438107","volume":"7","author":"AM Gravett","year":"2018","unstructured":"Gravett AM, Trautwein N, Stevanovic S, Dalgleish AG, Copier J. Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells. Oncoimmunology. 2018;7:e1438107.","journal-title":"Oncoimmunology"},{"key":"2132_CR29","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1007\/s00262-012-1307-4","volume":"61","author":"C Jackaman","year":"2012","unstructured":"Jackaman C, Majewski D, Fox SA, Nowak AK, Nelson DJ. Chemotherapy broadens the range of tumor antigens seen by cytotoxic CD8(+) T cells in vivo. Cancer Immunol Immunother. 2012;61:2343\u201356.","journal-title":"Cancer Immunol Immunother"},{"key":"2132_CR30","doi-asserted-by":"publisher","first-page":"5881","DOI":"10.1158\/1078-0432.CCR-17-1151","volume":"23","author":"V Gunda","year":"2017","unstructured":"Gunda V, Souchek J, Abrego J, Shukla SK, Goode GD, Vernucci E, et al. MUC1-mediated metabolic alterations regulate response to radiotherapy in pancreatic cancer. Clin Cancer Res. 2017;23:5881\u201391.","journal-title":"Clin Cancer Res"},{"key":"2132_CR31","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.celrep.2014.03.073","volume":"7","author":"T O\u2019Sullivan","year":"2014","unstructured":"O\u2019Sullivan T, Saddawi-Konefka R, Gross E, Tran M, Mayfield Stephen P, Ikeda H, et al. Interleukin-17D mediates tumor rejection through recruitment of natural killer cells. Cell Rep. 2014;7:989\u201398.","journal-title":"Cell Rep"},{"key":"2132_CR32","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1084\/jem.20151289","volume":"213","author":"K Masuda","year":"2016","unstructured":"Masuda K, Ripley B, Nyati KK, Dubey PK, Zaman MM, Hanieh H, et al. Arid5a regulates naive CD4+ T cell fate through selective stabilization of Stat3 mRNA. J Exp Med. 2016;213:605\u201319.","journal-title":"J Exp Med"},{"key":"2132_CR33","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.cell.2019.03.010","volume":"177","author":"NK Lytle","year":"2019","unstructured":"Lytle NK, Ferguson LP, Rajbhandari N, Gilroy K, Fox RG, Deshpande A, et al. A multiscale map of the stem cell state in pancreatic adenocarcinoma. Cell. 2019;177:572\u201386 e522.","journal-title":"Cell"},{"key":"2132_CR34","doi-asserted-by":"publisher","first-page":"57327","DOI":"10.18632\/oncotarget.16905","volume":"8","author":"R Wang","year":"2017","unstructured":"Wang R, Zhang Y, Lin X, Gao Y, Zhu Y. Prognositic value of CD73-adenosinergic pathway in solid tumor: a meta-analysis and systematic review. Oncotarget. 2017;8:57327\u201336.","journal-title":"Oncotarget"},{"key":"2132_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4073-7","volume":"18","author":"T Jiang","year":"2018","unstructured":"Jiang T, Xu X, Qiao M, Li X, Zhao C, Zhou F, et al. Comprehensive evaluation of NT5E\/CD73 expression and its prognostic significance in distinct types of cancers. BMC Cancer. 2018;18:267.","journal-title":"BMC Cancer"},{"key":"2132_CR36","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00109-018-01742-0","volume":"97","author":"L Zhou","year":"2019","unstructured":"Zhou L, Jia S, Chen Y, Wang W, Wu Z, Yu W, et al. The distinct role of CD73 in the progression of pancreatic cancer. J Mol Med (Berl). 2019;97:803\u201315.","journal-title":"J Mol Med (Berl)"},{"key":"2132_CR37","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1084\/jem.20062512","volume":"204","author":"S Deaglio","year":"2007","unstructured":"Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med. 2007;204:1257\u201365.","journal-title":"J Exp Med"},{"key":"2132_CR38","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1177\/0394632017711055","volume":"30","author":"N Ma","year":"2017","unstructured":"Ma N, Liu Q, Hou L, Wang Y, Liu Z. MDSCs are involved in the protumorigenic potentials of GM-CSF in colitis-associated cancer. Int J Immunopathol Pharm. 2017;30:152\u201362.","journal-title":"Int J Immunopathol Pharm"},{"key":"2132_CR39","doi-asserted-by":"crossref","unstructured":"Lee CR, Lee W, Cho SK, Park SG. Characterization of multiple cytokine combinations and TGF-beta on differentiation and functions of myeloid-derived suppressor cells. Int J Mol Sci. 2018;19:869.","DOI":"10.3390\/ijms19030869"},{"key":"2132_CR40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/jmcb\/mjr033","volume":"4","author":"DQ Tran","year":"2012","unstructured":"Tran DQ. TGF-beta: the sword, the wand, and the shield of FOXP3(+) regulatory T cells. J Mol Cell Biol. 2012;4:29\u201337.","journal-title":"J Mol Cell Biol"},{"key":"2132_CR41","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1084\/jem.20080308","volume":"205","author":"J Andersson","year":"2008","unstructured":"Andersson J, Tran DQ, Pesu M, Davidson TS, Ramsey H, O\u2019Shea JJ, et al. CD4+ FoxP3+ regulatory T cells confer infectious tolerance in a TGF-beta-dependent manner. J Exp Med. 2008;205:1975\u201381.","journal-title":"J Exp Med"},{"key":"2132_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01234-1","volume":"19","author":"C Li","year":"2020","unstructured":"Li C, Jiang P, Wei S, Xu X, Wang J. Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects. Mol Cancer. 2020;19:116.","journal-title":"Mol Cancer"},{"key":"2132_CR43","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10599","volume":"479","author":"TW Kang","year":"2011","unstructured":"Kang TW, Yevsa T, Woller N, Hoenicke L, Wuestefeld T, Dauch D, et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature. 2011;479:547\u201351.","journal-title":"Nature"},{"key":"2132_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.67","volume":"8","author":"P Bhat","year":"2017","unstructured":"Bhat P, Leggatt G, Waterhouse N, Frazer IH. Interferon-gamma derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity. Cell Death Dis. 2017;8:e2836.","journal-title":"Cell Death Dis"},{"key":"2132_CR45","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1189\/jlb.4RI0515-204R","volume":"98","author":"T Condamine","year":"2015","unstructured":"Condamine T, Mastio J, Gabrilovich DI. Transcriptional regulation of myeloid-derived suppressor cells. J Leukoc Biol. 2015;98:913\u201322.","journal-title":"J Leukoc Biol"},{"key":"2132_CR46","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1056\/NEJMc1713444","volume":"377","author":"M Yarchoan","year":"2017","unstructured":"Yarchoan M, Hopkins A, Jaffee EM. Tumor mutational burden and response rate to PD-1 inhibition. N. Engl J Med. 2017;377:2500\u20131.","journal-title":"N. Engl J Med"},{"key":"2132_CR47","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13046-019-1153-8","volume":"38","author":"CK Looi","year":"2019","unstructured":"Looi CK, Chung FF, Leong CO, Wong SF, Rosli R, Mai CW. Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment. J Exp Clin Cancer Res. 2019;38:162.","journal-title":"J Exp Clin Cancer Res"},{"key":"2132_CR48","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.canlet.2015.12.020","volume":"381","author":"K Foley","year":"2016","unstructured":"Foley K, Kim V, Jaffee E, Zheng L. Current progress in immunotherapy for pancreatic cancer. Cancer Lett. 2016;381:244\u201351.","journal-title":"Cancer Lett"},{"key":"2132_CR49","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1158\/1078-0432.CCR-16-2318","volume":"23","author":"BA Johnson 3rd","year":"2017","unstructured":"Johnson BA 3rd, Yarchoan M, Lee V, Laheru DA, Jaffee EM. Strategies for increasing pancreatic tumor immunogenicity. Clin Cancer Res. 2017;23:1656\u201369.","journal-title":"Clin Cancer Res"},{"key":"2132_CR50","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00262-004-0638-1","volume":"54","author":"JM Plate","year":"2005","unstructured":"Plate JM, Plate AE, Shott S, Bograd S, Harris JE. Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas. Cancer Immunol Immunother. 2005;54:915\u201325.","journal-title":"Cancer Immunol Immunother"},{"key":"2132_CR51","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4161\/onci.1.1.18068","volume":"1","author":"B Zhang","year":"2012","unstructured":"Zhang B. CD73 promotes tumor growth and metastasis. Oncoimmunology. 2012;1:67\u201370.","journal-title":"Oncoimmunology"},{"key":"2132_CR52","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1172\/JCI45559","volume":"121","author":"L Wang","year":"2011","unstructured":"Wang L, Fan J, Thompson LF, Zhang Y, Shin T, Curiel TJ, et al. CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice. J Clin Invest. 2011;121:2371\u201382.","journal-title":"J Clin Invest"},{"key":"2132_CR53","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1158\/0008-5472.CAN-10-4246","volume":"71","author":"J Stagg","year":"2011","unstructured":"Stagg J, Divisekera U, Duret H, Sparwasser T, Teng MW, Darcy PK, et al. CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis. Cancer Res. 2011;71:2892\u20132900.","journal-title":"Cancer Res"},{"key":"2132_CR54","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1073\/pnas.0908801107","volume":"107","author":"J Stagg","year":"2010","unstructured":"Stagg J, Divisekera U, McLaughlin N, Sharkey J, Pommey S, Denoyer D, et al. Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis. Proc Natl Acad Sci USA. 2010;107:1547\u201352.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2132_CR55","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jtbi.2012.03.024","volume":"303","author":"B Szomolay","year":"2012","unstructured":"Szomolay B, Eubank TD, Roberts RD, Marsh CB, Friedman A. Modeling the inhibition of breast cancer growth by GM-CSF. J Theor Biol. 2012;303:141\u201351.","journal-title":"J Theor Biol"},{"key":"2132_CR56","doi-asserted-by":"publisher","first-page":"e40677","DOI":"10.1371\/journal.pone.0040677","volume":"7","author":"MK Srivastava","year":"2012","unstructured":"Srivastava MK, Zhu L, Harris-White M, Kar UK, Huang M, Johnson MF, et al. Myeloid suppressor cell depletion augments antitumor activity in lung cancer. PLoS One. 2012;7:e40677.","journal-title":"PLoS One"},{"key":"2132_CR57","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1172\/JCI41936","volume":"121","author":"LA Mauti","year":"2011","unstructured":"Mauti LA, Le Bitoux MA, Baumer K, Stehle JC, Golshayan D, Provero P, et al. Myeloid-derived suppressor cells are implicated in regulating permissiveness for tumor metastasis during mouse gestation. J Clin Invest. 2011;121:2794\u2013807.","journal-title":"J Clin Invest"},{"key":"2132_CR58","doi-asserted-by":"publisher","first-page":"67152","DOI":"10.18632\/oncotarget.17934","volume":"8","author":"RJ King","year":"2017","unstructured":"King RJ, Yu F, Singh PK. Genomic alterations in mucins across cancers. Oncotarget. 2017;8:67152\u201368.","journal-title":"Oncotarget"},{"key":"2132_CR59","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey P, Chang DK, Nones K, Johns AL, Patch AM, Gingras MC, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016;531:47\u201352.","journal-title":"Nature"},{"key":"2132_CR60","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44\u201357.","journal-title":"Nat Protoc"},{"key":"2132_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"W Huang da","year":"2009","unstructured":"Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37:1\u201313.","journal-title":"Nucleic Acids Res"},{"key":"2132_CR62","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gky962","volume":"47","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa M, Sato Y, Furumichi M, Morishima K, Tanabe M. New approach for understanding genome variations in KEGG. Nucleic Acids Res. 2019;47:D590\u2013D595.","journal-title":"Nucleic Acids Res"},{"key":"2132_CR63","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27\u201330.","journal-title":"Nucleic Acids Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-021-02132-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-021-02132-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-021-02132-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T03:36:43Z","timestamp":1666841803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-021-02132-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,10]]},"references-count":63,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,2,11]]}},"alternative-id":["2132"],"URL":"https:\/\/doi.org\/10.1038\/s41388-021-02132-6","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,10]]},"assertion":[{"value":"20 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}